From Bench-to-Bedside: Translating Biomaterials Research *BTI* 2

Timeslot: Thursday, April 4, 2019 - 10:30am to 12:30pm
Track: Industry
Room: Yakima 1


The session will provide a podium for industry researchers developing a variety of innovative biomaterials-based technologies to give the audience perspective on the development process through specific examples. Talks will cover the entire R&D and translation from conception through licensing, preclinical development, clinical trials and commercialization.


Abstracts will be available for download on April 3, 2019.

  • 10:30:00 AM 189. Invited Speaker - Vincent Ling, Takeda,

  • 10:45:00 AM 190. Use of Nanomaterials to Develop Next Generation of Medical Device, M. Phaneuf*(1), S. Pathan(1), M. Contreras(2), N. Long(1), R. Kassab(1), B. Martino(1), A. Martin(1), G. Wong(1), M. Bide(3), T. Phaneuf(1); (1)BioSurfaces, Inc., Ashland, MA, USA, (2)BI Deaconess Medical Center, Boston, MA, USA, (3)University of Rhode Is

  • 11:00:00 AM 191. From Bench-to-Bedside: Licensing and Development of a Mineral-Organic Bone Adhesive for Bone Repair, M. Brown*(1), G. Kay(1), D. Cochran(2), J. Fiorellini(3), B. Hess(1); (1)LaunchPad Medical, LLC, Lowell, MA, USA, (2)University of Texas, San Antonio, TX, USA, (3)Penn State University, Philadelphia, PA, USA

  • 11:15:00 AM 192. Bringing Restorative Heart Valves Towards Clinical Practice, M. Cox*; Xeltis, Eindhoven, Netherlands

  • 11:30:00 AM 193. The Impact of Regenerative Therapies in the Clinic with Supporting Evidence from the Lab, R. Audet*(1), R. Diller(1), D. Dominguez(1), R. Kellar(1,2); (1)Axolotl Biologix Inc, Phoenix, AZ, USA, (2)Northern Arizona University, Flagstaff, AZ, USA

  • 11:45:00 AM 194. 3D-Painted Biomaterials: Hyperelastic Bone™, 3D-Graphene, Fluffy-X™, Tissue Papers, and More for Tissue Repair, Regeneration, and Biofabrication, A. Jakus*; Dimension Inx, LLC, Chicago, IL, USA

  • 12:00:00 PM 195. ABC103 from Bench to Bedside: Development of a Drug-Eluting Polymer Implant Which Prevents Post-Surgical Lung Cancer Recurrence, J. Schwartz*; AcuityBio Corporation, Newton, MA, USA

  • 12:15:00 PM 196. Sprayable Biopolymer Hydrogel for the Prevention of Postoperative Adhesions, L. Costella*(1), R. Villani(2), C. Tison(1); (1)Luna Innovations Incorporated, Charlottesville, VA, USA, (2)DaVINCI Biomedical Research Products, Lancaster, MA, USA

Invited Speaker(s)